Ilyang Pharmaceutical Co.,Ltd (KRX: 007570)

South Korea flag South Korea · Delayed Price · Currency is KRW
11,150
-70 (-0.62%)
Nov 15, 2024, 3:30 PM KST
-23.10%
Market Cap 199.95B
Revenue (ttm) 366.05B
Net Income (ttm) 641.57M
Shares Out 18.01M
EPS (ttm) 32.57
PE Ratio n/a
Forward PE n/a
Dividend 150.00 (1.35%)
Ex-Dividend Date n/a
Volume 63,056
Open 11,050
Previous Close 11,220
Day's Range 10,990 - 11,200
52-Week Range 10,990 - 16,250
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Nov 13, 2024

About Ilyang Pharmaceutical Co.,Ltd

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and be... [Read more]

Sector Healthcare
Founded 1946
Employees 651
Stock Exchange Korea Stock Exchange
Ticker Symbol 007570
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.